Drug General Information
Drug ID	D05UUA
Former ID	DNC006918
Drug Name	(+/-)-6-(2-chlorophenyl)cyclohex-3-enamine
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528488]
Structure		Download 2D MOL 3D MOL
Formula	C12H14ClN
Canonical SMILES	C1C=CCC(C1C2=CC=CC=C2Cl)N
InChI	1S/C12H14ClN/c13-11-7-3-1-5-9(11)10-6-2-4-8-12(10)14/h1-5,7,10,12H,6,8,14H2/t10-,12+/m1/s1
InChIKey	UAUINBMLUPAKPF-PWSUYJOCSA-N
PubChem Compound ID	16049437
Target and Pathway
Target(s)	Dipeptidyl peptidase IV	Target Info	Inhibitor	[528488]
KEGG Pathway	Protein digestion and absorption
NetPath Pathway	IL2 Signaling Pathway
	TGF_beta_Receptor Signaling Pathway
References
Ref 528488	J Med Chem. 2006 Nov 2;49(22):6439-42.Discovery of ((4R,5S)-5-amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a highly potent, selective, orally efficacious, and safe dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Ref 528488	J Med Chem. 2006 Nov 2;49(22):6439-42.Discovery of ((4R,5S)-5-amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a highly potent, selective, orally efficacious, and safe dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.